Aspen Aerogels (NYSE:ASPN - Get Free Report) is anticipated to announce its Q4 2024 earnings results after the market closes on Wednesday, February 12th. Analysts expect the company to announce earnings of $0.04 per share and revenue of $120.80 million for the quarter. Aspen Aerogels has set its Q1 2025 guidance at -0.180-0.000 EPS.Investors interested in participating in the company's conference call can do so using this link.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 5.06% and a net margin of 0.36%. On average, analysts expect Aspen Aerogels to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Aspen Aerogels Trading Down 23.7 %
Shares of ASPN traded down $2.79 during trading hours on Thursday, hitting $8.97. The company had a trading volume of 12,435,152 shares, compared to its average volume of 2,021,907. Aspen Aerogels has a 52-week low of $8.43 and a 52-week high of $33.15. The firm has a market cap of $735.58 million, a P/E ratio of 897.40 and a beta of 2.14. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The stock's 50 day moving average price is $12.36 and its 200 day moving average price is $18.63.
Analysts Set New Price Targets
Several analysts have weighed in on the company. StockNews.com raised Aspen Aerogels to a "sell" rating in a research report on Saturday, February 8th. HC Wainwright reiterated a "buy" rating and issued a $30.00 price objective on shares of Aspen Aerogels in a report on Wednesday, October 16th. Piper Sandler decreased their price objective on shares of Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating for the company in a report on Tuesday, October 22nd. Barclays decreased their price objective on shares of Aspen Aerogels from $27.00 to $25.00 and set an "overweight" rating for the company in a report on Tuesday, November 12th. Finally, Canaccord Genuity Group reduced their target price on shares of Aspen Aerogels from $28.00 to $20.00 and set a "buy" rating for the company in a report on Thursday, January 16th. One equities research analyst has rated the stock with a sell rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $29.11.
View Our Latest Research Report on ASPN
Aspen Aerogels Company Profile
(
Get Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Read More
Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
